All Eyes on Uludag University Academics' Study That Destroys Cancer Stem Cells. Uludag University Prof. Dr. It was revealed that patim and palladium-based metal complexes synthesized in the TÜBİTAK project carried out by Veysel T. Yılmaz and his team completely destroyed cancer stem cells.
THE EAR OF THE ONCOLOGY WORLD IS IN THE NEWS FROM THE TURKISH TEAM
Turkish scientists came up with a solution to end cancer radically. In the research carried out with the support of TÜBİTAK, it was determined that some compounds from 'platinum' and 'palladium' based metal complexes destroy cancer stem cells. The study, which had wide repercussions in the medical world, was carried out by Prof. Dr. It was made within the scope of the TÜBİTAK project carried out by Veysel T. Yılmaz. Of the two discovered palladium compounds, Prof. from the Faculty of Medicine, Department of Medical Biochemistry. Dr. Engin Ulukaya and his team found that they have strong anti-cancer effects. The compounds were patented by applying to the Turkish Patent Institute.
Effective in lung tumors
In the research of Uludağ Multidisciplinary Cancer Research Group, which was established by faculty members working in various faculties and departments of Uludağ University, it was determined that palladium compounds have a higher water solubility compared to platinum-based drugs, and therefore are in an advantageous position in terms of anti-cancer effect. The Cancer Research Group has so far investigated in detail the anticancer effect on breast, lung and prostate cancers.
First promising study
It was seen that cancer stem cells were killed in the 'Platinum and Palladium-Saccharine Complexes with Mixed Ligands' project, which was supported by TÜBİTAK up to 200 thousand TL. prof. Dr. Engin Ulukaya said, “The effect on prostate cancer stem cells in England was found to be more effective than the drugs used in the clinic. In terms of the effect of palladium compounds on prostate cancer stem cells, this study is the first in the world and the results are promising.
WORKS IN THE WORLD
There are few studies in this field in Turkey and in the world. In TÜBİTAK MAM in Turkey, Dr. Studies are carried out by Ceyda Açılan and her team. Its effects on experimental animals in Greece, on hematological tumors in Croatia, and on prostate cancer stem cells in England are still being studied abroad.
Tumor-fighting code to genes
Turkish and French scientists are working to ensure that drugs used in cancer treatment only affect cancerous cells by encoding genes, with the project carried out in partnership with TÜBİTAK and the French National Scientific Research Center. Experts from İzmir Economy and Dokuz Eylül Universities and Sorbonne, Paris Est and Northern Paris Universities came together to stop the spread of cancerous cells without damaging healthy cells.
The treatment will have the same effect on everyone.
Project leader Prof. Dr. In his statement, Cüneyt Güzeliş stated that the genes decide whether the drug is taken into a cell or not, and noted that in the study, they examine the behavior patterns of the genes in their interaction with each other. Güzeliş stated that they carried out their studies on colibacilli, the only living thing whose gene map is completely known, and that their ultimate goal is to produce drugs for cancer.